Compare
Side by side
Pick up to three peptides to see how their mechanisms, studied uses and evidence levels differ. Rows where the entries disagree are marked with a blue edge.
Selected 1 of 3
Comparison
Cosyntropin (tetracosactide)
Bone & endocrine
Evidence level
Strong evidence
Approval status
Approved drug
Mechanism of action
- 1.Binds the melanocortin-2 (ACTH) receptor on cells of the adrenal cortex.
- 2.Stimulates cortisol synthesis and release within 30 to 60 minutes.
- 3.The size of the cortisol rise is the test result: a flat response indicates adrenal insufficiency.
- 4.Has no meaningful effect on mineralocorticoid pathways at diagnostic doses.
- 5.Depot formulations extend adrenal stimulation over days.
Studied for
- Short ACTH stimulation (Synacthen) test for primary adrenal insufficiency
- Assessment after long-term steroid therapy
- Diagnostic work-up of suspected secondary adrenal insufficiency
- Adrenal response in critical illness research
- Short-term inflammatory conditions with the depot form
Reported effects
- A cortisol rise above the locally defined threshold in people with normal adrenal function
- Detection of adrenal suppression after prolonged steroid use
- No therapeutic effect beyond stimulating the adrenal cortex at diagnostic doses
Side effects
- Transient flushing
- Nausea
- Injection-site reactions
- Hypersensitivity, including rare anaphylaxis
- Fluid retention and electrolyte shifts with repeated depot use
- Worsening of allergic or asthmatic symptoms rarely reported with depot use
Research protocol
Research context only - diagnostic use. The standard short test uses 250 micrograms intramuscularly or intravenously with cortisol sampled at baseline, 30 and 60 minutes; low-dose variants use 1 microgram with more sensitive assays. Interpretation thresholds differ between assays and are set locally.
Research context only
Evidence justification
The reference standard for adrenal insufficiency diagnosis, with decades of comparative data against insulin tolerance and metyrapone testing.